Washington, D.C. – Congressman Dave Loebsack released the following statement today after the House of Representatives passed S. 920, the National Clinical Care Commission Act. This legislation will help improve and coordinate a national response to diabetes, and other metabolic and autoimmune diseases, by establishing a private-public Commission charged with making recommendations to streamline federal investments, as well as improving coordination and clinical care outcomes.